References
- Cunningham F G, Leveno K J, Bloom S L, Hauth J C, Gilstrap L C, III, Wenstrom K D. Hypertensive disorders in pregnancy. Williams obstetrics22nd ed. McGraw-Hill, New York 2005; 761–808
- Weiss J L, Malone F D, Emig D, Ball R H, Nyberg D A, Comstock C H, Saade G, Eddleman K, Carter S M, Craigo S D, et al. FASTER Research Consortium. Obesity, obstetric complications and cesarean deliver rate—a population based screening study. Am J Obstet Gynecol 2004; 190: 1091–1097
- Ramos G A, Caughey A B. The interrelationship between ethnicity and obesity on obstetric outcomes. Am J Obstet Gynecol 2005; 193: 1089–1093
- Ehrenberg H M, Dierker L, Milluzzi C, Mercer B M. Low maternal weight, failure to thrive in pregnancy, and adverse pregnancy outcomes. Am J Obstet Gynecol 2003; 189: 1726–1730
- Ness R B, Sibai B M. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol 2006; 195: 40–49
- Malone F D, Canick J A, Ball R H, Nyberg D A, Comstock C H, Bukowski R, Berkowitz R L, Gross S J, Dugoff L, Craigo S D, et al. First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005; 353: 2001–2111
- Nutrition during pregnancy. Part I: weight gain, part II: nutrient supplements. Institute of Medicine, National Academy Press, Washington, DC 1990
- Bodnar L M, Ness R A, Markovic N, Roberts J M. The risk of preeclampsia rises with increasing prepregnancy body mass index. Ann Epidemiol 2005; 15: 475–482
- Cedergren M I. Maternal obesity and the risk of adverse pregnancy outcome. Obstet Gynecol 2004; 103: 219–224
- Thadhani R, Stampfer M J, Hunter D J, Manson J E, Solomon C G, Curhan C G. High body mass index and hypercholesteremia: Risk of hypertensive disorders of pregnancy. Obstet Gynecol 1999; 94: 543–550
- Erez-Weiss I, Erez O, Shoham-Vardi I, Holcberg G, Mazor M. The association between maternal obesity, glucose intolerance and hypertensive disorders in nondiabetic pregnant women. Hypertens Pregnancy 2005; 24: 125–136
- Sebire N J, Jolly M, Harris J, Regan L, Robinson S. Is maternal underweight really a risk factor for adverse pregnancy outcome? A population-based study in London. Br J Obstet Gynaecol 2001; 108: 61–66
- Abenhaim H A, Kinch R A, Morin L, Benjamin A, Usher R. Effect of prepregnancy body mass index categories on obstetrical and neonatal outcomes. Arch Gynecol Obstet 2007; 275: 39–43
- Murakami M, Ohmichi M, Takahashi T, Shibata A, Fukao A, Morisaki N, Kurachi H, et al. Prepregnancy body mass index as an important predictor of perinatal outcomes in Japanese. Arch Gynecol Obstet 2005; 271: 311–315
- Barton J R, O'Nan J M, Bergauer N K, Jacques D L, Sibai B M. Does a lean prepregnancy body mass index influence outcome in pregnancies complicated by mild preeclampsia remote from term. Hypertens Pregnancy 2001; 20: 283–290
- Thadhani R, Ecker J L, Mutter W P, Wolf M, Smirnakis K V, Sukhatme V P, Levine R J, Karumanchi S A, et al. Insulin resistance and alterations in angiogenesis, additive insults that may lead to preeclampsia. Hypertension 2004; 43: 988–992
- Wolf M, Sandler L, Jimenez Kimble R, Shah A, Ecker J L, Thadhani R. Insulin resistance but not inflammation is associates with gestational hypertension. Hypertension 2002; 40: 886–891
- Van den Elzen H J, Wladimiroff J W, Cohen-Overbeek T E, de Bruijn A J, Grobbee D E. Serum lipids in early pregnancy and risk of pre-eclampsia. Br J Obstet Gynaecol 1996; 103: 117–122
- Kabiru W, Raynor D. Obstetric outcomes associated with increase in BMI category during pregnancy. Am J Obstet Gynecol 2004; 191: 928–932